Count the cost of disability caused by COVID-19

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

(2021) Frank G Sandmann et al.   LANCET INFECTIOUS DISEASES

High-dimensional characterization of post-acute sequelae of COVID-19

(2021) Ziyad Al-Aly et al.   NATURE

Toward universal health coverage in the post-COVID-19 era

(2021) Stéphane Verguet et al.   NATURE MEDICINE

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

(2021) Sarah E Daugherty et al.   BMJ-British Medical Journal

Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19

(2021) M. M. Walle-Hansen et al.   BMC Geriatrics

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

(2020) Kaja Abbas et al.   Lancet Global Health

Resource requirements for essential universal health coverage: a modelling study based on findings from Disease Control Priorities, 3rd edition

(2020) David A Watkins et al.   Lancet Global Health

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

(2020) Andrew Clark et al.   Lancet Global Health

The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements

(2020) Matthew Quaife et al.   BMC Medicine

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19

(2020) Andrew H. Briggs et al.   HEALTH ECONOMICS

When an emerging disease becomes endemic

(2017) Graham F. Medley et al.   SCIENCE

Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India

(2014) Anna Vassall et al.   Lancet Global Health

Legislating against Use of Cost-Effectiveness Information

(2010) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE